AstraZeneca and GSK, along with 10 other pharmaceutical companies, have formed a collaboration to procure renewable electricity for their operations in China. The initiative, which involves suppliers including Takeda and several others, is expected to unlock approximately 225GWh of renewable electricity annually. This will power facilities engaged in the research, development, and manufacturing of medicines
To continue reading this article, please subscribe:
Monthly PlanPrice: $30 / month Features:
|
Annual PlanPrice: $300 / year (Save 17%) Features:
|
Already a subscriber? Log in here:
